After months of declining cases in the U.S., COVID-19 is once again spiking—an alarming public health trend that could disrupt states reopening and loosening lockdown measures.

The pilot notched a 100% success rate and may ultimately help patients and doctors decide between medication and surgery.

Provider groups can potentially use subsidiaries for different markets or different payer arrangements based on the new guidance, experts advised. 

There was no significant difference when the athlete had diabetes or hypertension.

As machine learning progresses from research settings to clinical practice, how are clinicians to know they can trust the machine’s conclusions to guide care for actual patients?

Unhappy with existing methods for delivering stem cells to the heart, a team of researchers has developed an exosome solution that can be sprayed through a tiny incision.

Winners of the 10th annual Brain Tumor Segmentation challenge will be recognized at the AI Showcase Theater during RSNA 2021.

Methamphetamine-related heart failure hospitalizations increased 585% from 2008 to 2018, researchers found. 

Hawaiian researchers found merely recommending providers utilize higher D-dimer requirements wasn't enough to decrease CTPA orders and increase positivity rates.

The 'right to repair' debate is one that could impact heart teams and device manufacturers for years to come. Some hospitals have had a head start, accusing one company of unfair repair policies that put patients at risk.